methoxyhydroxyphenylglycol has been researched along with Substance-Related Disorders in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (47.62) | 18.7374 |
| 1990's | 7 (33.33) | 18.2507 |
| 2000's | 3 (14.29) | 29.6817 |
| 2010's | 1 (4.76) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Consorti, M; Gerra, G; Mercolini, L; Raggi, MA; Somaini, L | 1 |
| Laorden, ML; Milanés, MV; Navarro-Zaragoza, J; Núñez, C | 1 |
| Kalivas, PW; Middaugh, LD; Szumlinski, KK; Toda, S; Worley, PF | 1 |
| Furlanetto, S; Gerra, G; Mandrioli, R; Pinzauti, S; Raggi, MA; Sabbioni, C; Saracino, MA | 1 |
| Charney, DS; Galloway, MP; Heninger, GR; Kleber, HD; Murberg, M; Redmond, DE; Roth, RH | 1 |
| Davis, JM; De Leon-Jones, FA; Dekirmenjian, H; Inwang, EE | 1 |
| Black, JE; Heninger, GR; Kosten, TR; Malison, RT; McDougle, CJ; Price, LH; Zimmermann, RC | 1 |
| Moss, HB; Yao, JK | 1 |
| Goto, K; Ikemoto, S; Ishiguro, T; Yui, K | 1 |
| Charney, DS; Heninger, GR; Jatlow, PI; Kosten, TR; Krystal, JH; Petrakis, IL; Stine, SM | 1 |
| Karoum, F; Majchrowicz, E; Wyatt, RJ | 1 |
| Heninger, GR; Kleber, HD; Kosten, TR; McDougle, CJ; Palumbo, JM; Price, LH | 1 |
| Finnegan, KT; Irwin, I; Langston, JW; Ricaurte, GA | 1 |
| Bowers, MB; Jatlow, PI; Mazure, CM; Nelson, JC | 1 |
| Burns, RS; Ebert, MH; Kopin, IJ; LeWitt, PA; Pakkenberg, H | 1 |
| Galloway, MP; Lodhi, R; Martin, SD; Yeragani, VK | 1 |
| Davis, CM; Demer, JL; Krajewski, K; Porter, FI; Ulrich, I; Volkow, ND | 1 |
| Griffin, ML; Michael, J; Mirin, SM; Weiss, RD | 1 |
| Esposito, E; Kruszewska, A; Ossowska, G; Samanin, R | 1 |
| Sherer, MA | 1 |
| Tennant, FS | 1 |
1 review(s) available for methoxyhydroxyphenylglycol and Substance-Related Disorders
| Article | Year |
|---|---|
Psychopathology in substance abusers: diagnosis and treatment.
Topics: Blood Platelets; Depressive Disorder; Female; Humans; Male; Methoxyhydroxyphenylglycol; Monoamine Oxidase; Mood Disorders; Pedigree; Psychological Tests; Substance-Related Disorders | 1988 |
4 trial(s) available for methoxyhydroxyphenylglycol and Substance-Related Disorders
| Article | Year |
|---|---|
Naltrexone precipitated opiate withdrawal in methadone addicted human subjects: evidence for noradrenergic hyperactivity.
Topics: Adult; Blood Pressure; Brain; Female; Humans; Kinetics; Male; Methadone; Methoxyhydroxyphenylglycol; Naloxone; Naltrexone; Narcotics; Norepinephrine; Substance Withdrawal Syndrome; Substance-Related Disorders | 1984 |
Noradrenergic dysregulation during discontinuation of cocaine use in addicts.
Topics: Administration, Intranasal; Adult; Cocaine; Double-Blind Method; Female; Hospitalization; Humans; Hydrocortisone; Infusions, Intravenous; Insufflation; Male; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Panic Disorder; Prospective Studies; Single-Blind Method; Substance Withdrawal Syndrome; Substance-Related Disorders; Yohimbine | 1994 |
Plasma monoamine metabolites and spontaneous recurrence of methamphetamine-induced paranoid-hallucinatory psychosis: relation of noradrenergic activity to the occurrence of flashbacks.
Topics: Adult; Antipsychotic Agents; Dopamine; Female; Hallucinations; Homovanillic Acid; Humans; Methamphetamine; Methoxyhydroxyphenylglycol; Middle Aged; Neurotransmitter Agents; Norepinephrine; Paranoid Disorders; Prisoners; Recurrence; Serotonin; Substance-Related Disorders | 1996 |
Effect of alpha-methyl-para-tyrosine on response to cocaine challenge.
Topics: Administration, Oral; Adult; alpha-Methyltyrosine; Arousal; Cocaine; Diphenhydramine; Dopamine; Double-Blind Method; Enzyme Inhibitors; Euphoria; Female; Homovanillic Acid; Humans; Male; Methoxyhydroxyphenylglycol; Methyltyrosines; Middle Aged; Norepinephrine; Prolactin; Substance-Related Disorders | 1997 |
16 other study(ies) available for methoxyhydroxyphenylglycol and Substance-Related Disorders
| Article | Year |
|---|---|
Fast analysis of catecholamine metabolites MHPG and VMA in human plasma by HPLC with fluorescence detection and a novel SPE procedure.
Topics: Catecholamines; Chromatography, High Pressure Liquid; Fluorescence; Humans; Methoxyhydroxyphenylglycol; Substance-Related Disorders; Vanilmandelic Acid | 2009 |
Effects of corticotropin-releasing factor receptor-1 antagonists on the brain stress system responses to morphine withdrawal.
Topics: Adrenocorticotropic Hormone; Animals; Brain; Brain Stem; Corticosterone; Iodine Radioisotopes; Male; Methoxyhydroxyphenylglycol; Morphine; Norepinephrine; Proto-Oncogene Proteins c-fos; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Receptors, Corticotropin-Releasing Hormone; Stress, Psychological; Substance Withdrawal Syndrome; Substance-Related Disorders; Tyrosine 3-Monooxygenase | 2010 |
Evidence for a relationship between Group 1 mGluR hypofunction and increased cocaine and ethanol sensitivity in Homer2 null mutant mice.
Topics: Animals; Carrier Proteins; Central Nervous System Depressants; Cocaine; Conditioning, Operant; Ethanol; Excitatory Amino Acid Agonists; Homer Scaffolding Proteins; Methoxyhydroxyphenylglycol; Mice; Mice, Knockout; Motor Activity; Neuronal Plasticity; Neuropeptides; Receptors, Metabotropic Glutamate; Reward; Substance-Related Disorders | 2003 |
Simultaneous liquid chromatographic analysis of catecholamines and 4-hydroxy-3-methoxyphenylethylene glycol in human plasma. Comparison of amperometric and coulometric detection.
Topics: Case-Control Studies; Catecholamines; Electrochemistry; Humans; Methoxyhydroxyphenylglycol; Reproducibility of Results; Sensitivity and Specificity; Substance-Related Disorders | 2004 |
Excretion of catecholamine metabolites during methadone maintenance and withdrawal.
Topics: Adult; Epinephrine; Female; Heroin Dependence; Humans; Male; Metanephrine; Methadone; Methoxyhydroxyphenylglycol; Norepinephrine; Normetanephrine; Substance Withdrawal Syndrome; Substance-Related Disorders; Vanilmandelic Acid | 1983 |
Associations of beta-endorphin with HVA and MHPG in the plasma of prepubertal boys: effects of familial drug abuse and antisocial personality disorder liability.
Topics: Alcoholism; Antisocial Personality Disorder; beta-Endorphin; Child; Child of Impaired Parents; Fathers; Homovanillic Acid; Humans; Illicit Drugs; Male; Methoxyhydroxyphenylglycol; Personality Assessment; Psychotropic Drugs; Risk Factors; Substance-Related Disorders | 1996 |
Brain concentrations of biogenic amine metabolites in acutely treated and ethanol-dependent rats.
Topics: Animals; Biogenic Amines; Brain Chemistry; Dopamine; Ethanol; Humans; Male; Mandelic Acids; Methoxyhydroxyphenylglycol; Norepinephrine; Octopamine; Phenylacetates; Rats; Substance-Related Disorders; Tyramine; Vanilmandelic Acid | 1976 |
Dopaminergic responsivity during cocaine abstinence: a pilot study.
Topics: Adult; Carbidopa; Cocaine; Dopamine Agents; Drug Combinations; Growth Hormone; Homovanillic Acid; Humans; Levodopa; Male; Methoxyhydroxyphenylglycol; Middle Aged; Prolactin; Receptors, Dopamine; Substance Withdrawal Syndrome; Substance-Related Disorders | 1992 |
Aminergic metabolites in cerebrospinal fluid of humans previously exposed to MDMA: preliminary observations.
Topics: 3,4-Methylenedioxyamphetamine; Adult; Biogenic Amines; Designer Drugs; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; N-Methyl-3,4-methylenedioxyamphetamine; Reference Values; Substance-Related Disorders | 1990 |
Psychotogenic drug use and neuroleptic response.
Topics: Adolescent; Adult; Antipsychotic Agents; Bipolar Disorder; Depressive Disorder; Haloperidol; Homovanillic Acid; Humans; Male; Methoxyhydroxyphenylglycol; Perphenazine; Psychiatric Status Rating Scales; Psychotic Disorders; Psychotropic Drugs; Schizophrenia; Schizophrenic Psychology; Substance-Related Disorders | 1990 |
The clinical syndrome of striatal dopamine deficiency. Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adult; Corpus Striatum; Dopamine; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Parkinson Disease; Parkinson Disease, Secondary; Pyridines; Substance-Related Disorders; Substantia Nigra; Syndrome | 1985 |
Clinical ratings and plasma HVA during cocaine abstinence.
Topics: Adult; Cocaine; Homovanillic Acid; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Substance Withdrawal Syndrome; Substance-Related Disorders | 1989 |
Eye movements in cocaine abusers.
Topics: Adult; Caloric Tests; Cocaine; Eye Movements; Female; Humans; Male; Methoxyhydroxyphenylglycol; Nystagmus, Physiologic; Psychiatric Department, Hospital; Pursuit, Smooth; Reflex, Vestibulo-Ocular; Saccades; Substance-Related Disorders | 1989 |
Noradrenergic and behavioural effects of naloxone injected in the locus coeruleus of morphine-dependent rats and their control by clonidine.
Topics: Animals; Behavior, Animal; Clonidine; Locus Coeruleus; Male; Methoxyhydroxyphenylglycol; Morphine; Naloxone; Neurons; Norepinephrine; Rats; Substance-Related Disorders | 1987 |
Intravenous cocaine: psychiatric effects, biological mechanisms.
Topics: Adult; Arousal; Brain; Chromatography, High Pressure Liquid; Cocaine; Dose-Response Relationship, Drug; Euphoria; Haloperidol; Homovanillic Acid; Humans; Infusions, Intravenous; Male; Methoxyhydroxyphenylglycol; Norepinephrine; Premedication; Psychoses, Substance-Induced; Substance-Related Disorders | 1988 |
Effect of cocaine dependence on plasma phenylalanine and tyrosine levels and on urinary MHPG excretion.
Topics: Adult; Cocaine; Female; Glycols; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Phenylalanine; Substance-Related Disorders; Tyrosine | 1985 |